Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trafermin - Kaken Pharmaceutical

Drug Profile

Trafermin - Kaken Pharmaceutical

Alternative Names: CAB 2001; Fiblast Spray; KCB-1; KCB-1B; KCB-1D; REGROTH Dental Kit

Latest Information Update: 14 Sep 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Scios
  • Developer Kaken Pharmaceutical; Olympus Corporation; Scios
  • Class Fibroblast growth factors; Peptide fragments; Vascular disorder therapies
  • Mechanism of Action Fibroblast growth factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Skin ulcer
  • Registered Periodontitis
  • Discontinued Coronary disorders; Diabetic foot ulcer; Fracture; Peripheral vascular disorders; Postmenopausal osteoporosis; Stroke

Most Recent Events

  • 05 Sep 2018 Taxus Cardium Pharmaceuticals Group is now called Gene Biotherapeutics
  • 22 Dec 2016 Biomarkers information updated
  • 28 Sep 2016 Registered for Periodontitis in Japan (Topical)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top